Comparative effectiveness of sacubitril/valsartan versus angiotensin converting enzyme inhibitors/angiotensin receptor blockers in de novo heart failure patients
Event:
ESC Congress 2022
Topic:
Pharmacotherapy
Session:
Heart failure pharmacotherapy - Sacubitril/valsartan
